对帕金森病拷贝数变异的全基因组关联研究
Zied Landoulsi1,2, Ashwin Ashok Kumar Sreelatha3, Claudia Schulte4,5
1Luxembourg Centre for Systems Biomedicine, University of Luxembourg; L-4367, Esch-sur-Alzette, Luxembourg.
medRxiv : the preprint server for health sciences
|September 4, 2024
概括
副本数变异 (CNVs) 显著影响帕金森病 (PD) 的病原性. 这项研究发现PD患者的CNV负担更高,特别是PRKN基因,与早期发病PD (EOPD) 的早期疾病发病有关.
科学领域:
- 遗传学 是一个遗传学.
- 神经科学是一个神经科学.
- 基因组学就是基因组学.
背景情况:
- 帕金森病 (PD) 是一种复杂的神经退行性疾病,具有重要的遗传成分.
- 了解基因变异的作用,如副本数变异 (CNVs),对于阐明PD病变的产生至关重要.
- 特别是零星的PD,需要进一步研究其潜在的遗传机制.
研究的目的:
- 为了研究CNVs对帕金森病 (PD) 病原学的影响.
- 为了确定涉及CNVs在零星PD中的新型遗传机制.
- 提高对 CNVs 在 PD 发展中的作用的理解.
主要方法:
- 全基因组关联研究 (GWAS) 使用移动窗口方法来检测CNV.
- 分析来自大型队列的CNV数据:11,035名PD患者 (包括2,731名早期发病的PD) 和8,901名对照.
- 在CNV数据上进行了全基因组负担分析.
主要成果:
- 确定了14个与PD相关的全基因组显著的CNV位点 (1删除,13重复).
- 在PD患者中发现了显著的CNV负担 (OR=1.56),其中PRKN显示了最高负担 (OR=1.47) 和与EOPD早期发病的关联.
- 发现了新的CNV区域,并在EOPD中证实了显著的CNV负担,主要是由PRKN基因驱动的.
结论:
- 这是迄今为止PD中最大的基于CNV的GWAS.
- 在早期发病的PD (EOPD) 中证实了显著的CNV负担,主要与PRKN基因有关.
- 确定了新的CNV区域,并强调了进一步调查PRKN和其他CNV在PD中的重要性.
相关概念视频
Comparing Copy Number Variations and SNPs
17.7K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.7K
Genome-wide Association Studies-GWAS
13.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.2K
Single Nucleotide Polymorphisms-SNPs
14.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.9K
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
Parkinson's Disease: Overview
499
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
499


